Response of anti-NMDA receptor encephalitis without tumor to immunotherapy including rituximab.
Ishiura
H
H
Department of Neurology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.
Matsuda
S
S
Higashihara
M
M
Hasegawa
M
M
Hida
A
A
Hanajima
R
R
Yamamoto
T
T
Shimizu
J
J
Dalmau
J
J
Tsuji
S
S
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D004660:Encephalitis / Q000000981:diagnostic imaging / Q000473:pathology / Q000628:therapy*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007167:Immunotherapy / Q000379:methods*; D008279:Magnetic Resonance Imaging / Q000379:methods; D049268:Positron-Emission Tomography / Q000379:methods; D016194:Receptors, N-Methyl-D-Aspartate / Q000276:immunology*; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D016194:Receptors, N-Methyl-D-Aspartate; D000069283:Rituximab